Advanced search
Publication Cover
Acta Cardiologica Volume 70, 2015 - Issue 2
Submit an article Journal homepage
14
Views
8
CrossRef citations to date
0
Altmetric
Articles

Metabolic syndrome: influence on clinical severity and prognosis in patients with acute ST-elevation myocardial infarction treated with primary percutaneous coronary intervention

Marko Mornar JelavicCenter for Internal Medicine and Dialysis, Health Center Zagreb-East, Zagreb, CroatiaCorrespondenceE-mail: [email protected]
, Md;,
Zdravko BabicCoronary Care Unit, University Hospital “Sestre Milosrdnice”, Zagreb, Croatia
, Md, Phd; &
Hrvoje PintaricCardiac Catheterisation Laboratory, University Hospital “Sestre Milosrdnice”, Zagreb, Croatia
, Md, Phd
Pages 149-156 | Received 02 Nov 2014, Accepted 22 Dec 2014, Published online: 23 May 2017

  • Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech 2009; 2:231–7.
  • Kassi E, Pervanidou P. Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMCMed 2011; 9:48.
  • Batsis JA, Nieto-Martinez RE, Lopez-Jimenez F. Metabolic syndrome: from global epidemiology to individualized medicine. Clin Pharmacol Ther 2007; 82: 509–24.
  • Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008; 28:629–36.
  • Qiao Q Tuomilehto J, Balkau B, Borch-Johnsen K, Heine R, Wareham NJ; DECODE Study Group. Are insulin resistance, impaired fasting glucose and impaired glucose tolerance all equally strongly related to age? Diabet Med 2005; 22: 1476–81.
  • Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyörälä K; DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004; 164: 1066–76.
  • Hu G, Qiao Q, Tuomilehto J, Eliasson M, Feskens EJ, Pyörälä K; DECODE Insulin Study Group. Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia 2004; 47: 1245–56.
  • CoutinhoT, Goel K, Correa de Sá D, Kragelund C, Kanaya AM, Zeller M, Park JS, Kober L, Torp-Pedersen C, Cottin Y, Lorgis L, Lee SH, Kim YJ, Thomas R, Roger VL, Somers VK, Lopez-Jimenez F. Central obesity and survival in subjects with coronary artery disease:a systematic review of the literature and collabora-tive analysis with individual subject data. J Am Coll Cardiol 2011; 57: 1877–86.
  • Lakka HM, Lakka TA, Tuomilehto J, Salonen JT. Abdominal obesity is associated with increased risk of acute coronary events in men. Eur HeartJ 2002; 23:706–13.
  • Jover A, Corbella E, Mufioz A, Milian J, Pinto X, Mangas A, ZOffiga M, Pedro-Botet J, Hernändez-Mijares A. Prevalence of metabolic syndrome and its components in patients with acute coronary syndrome. Rev Esp Cardiol 2011; 64:579–86 [article in Spanish].
  • Zalionas R, Slapikas R, Babarskiene R, Slapikiene B, Luksiene D, Milvidaite I, Laukaitiene J. The prevalence of the metabolic syndrome components and their combinations in men and women with acute ischemic syndromes. Medicina (Kaunas) 2008; 44:521–8.
  • Feinberg MS, Schwartz R, Behar S. Impact of metabolic syndrome in patients with acute coronary syndrome. Adv Cardiol 2008; 45: 114–26.
  • Lee MG, Jeong MH, Ahn Y, Chae SC, Hur SH, Hong TJ, Kim YJ, Seong IW, Chae JK, Rhew JY, Chae IH, Cho MC, Bae JH, Rha SW, Kim CJ, Choi D, Jang YS, Yoon J, Chung WS, Cho JG, Seung KB, Park SJ. Impact of the metabolic syndrome on the clinical outcome of patients with acute ST-elevation myocardial infarction. J Korean Med Sci 2010; 25:1456–61.
  • Zeller M, Steg PG, Ravisy J, Laurent Y, Janin-Manificat L, LHuillier I, Beer JC, Oudot A, Rioufol G, Makki H, Farnier M, Rochette L, Verges B, Cottin Y; Observatoire des Infarctus de Cote-d’Or Survey Working Group. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med 2005; 165: 1192–8.
  • Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M; ESC Committee for Practice Guidelines (CPG). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29:2909–45.
  • Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, Kolh P. Danchin N, Di Mario C, Falk V, Folliguet T, Garg 5, Huber K, James 5, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, PomarJL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P. Serruys PW, Silber 5, Sousa Uva M, Taggart D. Guidelines on myocardial revascularization. Eur Heart J 2010; 31:2501–55.
  • Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon DC, Murphy ML, Roe BB. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51(4 Suppl): 5–40.
  • Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL, Douglas PS, Faxon DP, Gillam LD, Kimball TR, Kussmaul WG, Pearlman AS, Philbrick JT, Rakowski H, Thys DM, Antman EM, Smith SC Jr, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO; American College of Cardiology; American Heart Association; American Society of Echocardiography. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation 2003; 108:1146–62.
  • Miller AM, Alcaraz Ruiz A, Borrayo Sanchez G, Almeida Gutiérrez E, Vargas Guzman RM, Jäuregui Aguilar R. Metabolic syndrome: clinical and angiographic impact on patients with acute coronary syndrome. Cir Cir 2010; 78:113–20.
  • Clavijo LC, Pinto TL, Kuchulakanti PK, Torguson R, Chu WW, Satler LF, Kent KM, Suddath WO, Pichard AD, Waksman R. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. Cardiovasc Revasc Med 2006; 7: 7–11.
  • Ji MS, Jeong MH, Ahn Y, Kim YJ, Chae SC, Hong TJ, Seong IW, Chae JK, Kim CJ, Cho MC, Rha SW, Bae JH, Seung KB, Park SJ; Other Korea Acute Myocardial Infarction Registry Investigators. One-Year Clinical Outcomes among Patients with Metabolic Syndrome and Acute Myocardial Infarction. Korean Circ J 2013; 43: 519–26.
  • Bohmer E, Seljeflot I, Arnesen H, Hoffmann P. Abdelnoor M, Halvorsen S.The association between metabolic syndrome and infarct size in patients with acute myocardial infarction. Scand J Clin Lab Invest 2010; 70:287–93.
  • Hoffmann R, Stellbrink E, Schröder J, Grawe A, Vogel G, Blindt R, Kelm M, Radke PW. Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents. Am J Cardiol 2007; 100: 1347–52.
  • Rana JS, Monraats PS, Zwinderman AH, de Maat MP, Kastelein JJ, Doevendans PA, de Winter RJ, Tio RA, Frants RR, van der Laarse A, van der Wall EE, Jukema JW; GENDER study. Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention. Diabetes Care 2005; 28:873–7.
  • Iglesias Bolarlos P. Olivar Roldán J, Perialver Talavera D, Diaz Guardiola P. Vega Piller° B, Monereo Megias S. Effect of abdominal obesity on size of myocardial infarction. Endocrinol Nutr 2009; 56:4–8 [article in Spanish].
  • Azarfarin R, Samadikhah J, Shahvalizadeh R, Golzari SE. Evaluation of anthropometric indices of patients with left ventricle dysfunction following first acute anterior myocardial infarction. J Cardiovasc Thorac Res 2012; 4: 11–5.
  • Bechlioulis A, Vakalis K, Naka KK, Bourantas CV, Papamichael ND, Kotsia A, Tzimas T, Pappas K, Katsouras CS, Michalis LK. Paradoxical protective effect of central obesity in patients with suspected stable coronary artery disease. Obesity (Silver Spring) 2013; 21: E314–21.
  • Martins A, Ribeiro 5, Gonçalves P. Correia A. Role of central obesity in risk stratification after an acute coronary event: does central obesity add prognostic value to the Global Registry of Acute Coronary Events (GRACE) risk score in patients with acute coronary syndrome? Rev Port Cardiol 2013; 32: 769–76.
  • Lopes de Souza PA, Trussardi Fayh AP, LOcia Portal V. Abdominal circumference as a predictor of 30-day outcome in acute coronary syndrome. Arq Bras Cardiol 2011; 96: 399–404.
  • Seidell JC, Pérusse L, Després JP, Bouchard C. Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study. Am J Clin Nutr 2001; 74:315–21.
  • See R, Abdullah SM, McGuire DK, Khera A, Patel MJ, Lindsey JB, Grundy SM, de LemosJA. The association of differing measures of overweight and obesity with prevalent atherosclerosis: the Dallas Heart Study. J Am Coll Cardiol 2007; 50:752–9.
  • Zen V, Fuchs FD, Wainstein MV, Gonçalves SC, Biavatti K, Riedner CE, Fuchs FC, Wainstein RV, Rhoden EL, Ribeiro JP, Fuchs SC. Neck circumference and central obesity are independent predictors of coronary artery disease in patients undergoing coronary angiography. Am J Cardiovasc Dis 2012; 2: 323–30.
  • Lee SH, Park JS, Kim W, Shin DG, Kim YJ, Kim DS, Choi DJ, Han KR, Kim CJ, Cho MC, Chae SC, Jeong MH; Korean Acute Myocardial Infarction Registry Investigators. Impact of body mass index and waist-to-hip ratio on clinical outcomes in patients with ST-segment elevation acute myocardial infarction (from the Korean Acute Myocardial Infarction Registry). Am J Cardiol 2008; 102: 957–65.
  • Sönmez K, Akçakoyun M, Akçay A, Demir D, Duran NE, GerKbay M, Degertekin M, Turan F. Which method should be used to determine the obesity, in patients with coronary artery disease? (body mass index, waist circumference or waist-hip ratio). Obes Relat Metab Disord 2003; 27: 341–6.
  • Dobbelsteyn CJ, Joffres MR, MacLean DR, Flowerdew G. A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys. Obes Relat Metab Disord 2001; 25: 652–61.
  • Kang WY, Jeong MH, Ahn YK, Kim JH, Chae SC, Kim YJ, Hur SH, Seong IW, Hong TJ, Choi DH, Cho MC, Kim CJ, Seung KB, Chung WS, Jang YS, Rha SW, Bae JH, Cho JG, Park SJ; Korea Acute Myocardial Infarction Registry Investigators. Obesity paradox in Korean patients undergoing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. J Cardiol 2010; 55:84–91.
  • Mehta L, Devlin W, McCullough PA, O’Neill WW, Skelding KA, Stone GW, Boura JA, Grines CL. Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol 2007; 99: 906–10.
  • Babic Z, Pavlov M, Bulj N, Heitzler VN, Mitrovic V, Hamm C, Weber M. Metabolic syndrome and outcome in patients with acute myocardial infarction. Acta Clin Croat 2011; 50: 193–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.